Patent details

Basic Information

Publication number:

EP2970477

PCT Application Number:

US2014029253

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147179543

PCT Publication Number:

WO2014144722

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BISPECIFIC-FC MOLECULES

French Title of Invention:

MOLÉCULES FC BISPÉCIFIQUES

German Title of Invention:

BISPEZIFISCHE FC-MOLEKÜLE

SPC Number:

Dates

Filing date:

14/03/2014

Grant date:

04/10/2023

EP Publication Date:

20/01/2016

PCT Publication Date:

18/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/10/2023

EP B1 Publication Date:

04/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/03/2024

Expiration date:

14/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/09/2023

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

1

Name:

MICHAELS, Mark L.

Address:

United States (US)

2

Name:

YAN, Wei

Address:

United States (US)

3

Name:

BORGES, Luis G.

Address:

United States (US)

4

Name:

BAEUERLE, Patrick A.

Address:

Germany (DE)

Priority

Priority Number:

201361791424 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; C07K 16/32; C07K 16/46;

Publication

European Patent Bulletin

Issue number:

202340

Publication date:

04/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages